Novasep to supply API to Celladon; FDA OKs Kemwell plant; Recipharm and Adroit work together;

> Novasep and Celladon have an API supply agreement for Novasep to manufacture Celladon's genetically targeted enzyme replacement therapy MYDICAR. Release

> Horizon Discovery Group has received £652,000 from the U.K.'s Advanced Manufacturing Supply Chain Initiative to expand bioproduction research into how to accelerate the development of novel and improved Chinese hamster ovary cell lines. Report

> Bangalore, India-based CDMO Kemwell says it has successfully passed an FDA inspection tied to an ANDA submitted by a client. Release

> CDMO Recipharm will begin using solid state characterization services from Adroit Science. Release

And Finally... A compounders group is discouraging members from providing drugs for state executions. Story